Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0022661
Disease: Kidney Failure, Chronic
Kidney Failure, Chronic
0.100 GeneticVariation disease GWASCAT Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study. 31178898 2019
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.020 GeneticVariation group BEFREE Lifestyle modification plays a key role in nonalcoholic fatty liver disease (NAFLD) and colorectal adenoma and/or cancer (CRA/CRC) development. 30791768 2019
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.020 GeneticVariation group BEFREE Despite limited power, there was a trend toward improved OS for the 13-CRA arm (HR, 0.75; P = .14), particularly among patients whose index tumor was surgically excised (N = 26; HR, 0.50; P = .057) and among women (N = 39; HR, 0.44; P = .065) and never/former smokers (N = 129; HR, 0.61; P = .055), with a median follow-up of 16 years. 28786105 2017
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.020 GeneticVariation group BEFREE Lifestyle modification plays a key role in nonalcoholic fatty liver disease (NAFLD) and colorectal adenoma and/or cancer (CRA/CRC) development. 30791768 2019
CUI: C0042514
Disease: Tachycardia, Ventricular
Tachycardia, Ventricular
0.010 GeneticVariation disease BEFREE The cardiac rhythm as primary origin of the CRA was ventricular fibrillation (VF) in 16 patients (61.5%), asystole in 8 patients (34.6%) and ventricular tachycardia (VT) in one patient (3.8%). 29275174 2018
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.020 Biomarker group BEFREE Since a large number of triterpenoid compound has marked anticancer effects toward various types of cancer cell lines in vitro, this study was carried out to investigate the anticancer effect of CRA in human gastric cancer cell line BGC823 cells and the underlying apoptotic mechanism of CRA was examined in BGC823 cell lines. 28506699 2017
CUI: C0018801
Disease: Heart failure
Heart failure
0.020 Biomarker disease BEFREE RBM25/LUC7L3 function in cardiac sodium channel splicing regulation of human heart failure. 22939879 2013
CUI: C0018802
Disease: Congestive heart failure
Congestive heart failure
0.020 Biomarker disease BEFREE RBM25/LUC7L3 function in cardiac sodium channel splicing regulation of human heart failure. 22939879 2013
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.020 Biomarker group BEFREE CRA-026440 parenterally given to mice harboring HCT116 or U937 human tumor xenografts resulted in a statistically significant reduction in tumor growth. 16891455 2006
CUI: C0028754
Disease: Obesity
Obesity
0.020 Biomarker disease BEFREE We aimed to evaluate whether obesity was associated with a certain clinicopathologic characteristics of metachronous CRA. 29079785 2017
CUI: C0028754
Disease: Obesity
Obesity
0.020 Biomarker disease BEFREE We adjusted the CRA approach to purely capture obesity (BMI ≥ 30 kg/m²). 30274272 2018
CUI: C0400966
Disease: Non-alcoholic Fatty Liver Disease
Non-alcoholic Fatty Liver Disease
0.020 Biomarker disease BEFREE These results demonstrated that CRA might protect the liver injury by its anti-oxidant effect, which could be a potential therapeutic agent of NAFLD. 29803928 2018
CUI: C0400966
Disease: Non-alcoholic Fatty Liver Disease
Non-alcoholic Fatty Liver Disease
0.020 Biomarker disease BEFREE Lifestyle modification plays a key role in nonalcoholic fatty liver disease (NAFLD) and colorectal adenoma and/or cancer (CRA/CRC) development. 30791768 2019
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.020 Biomarker group BEFREE Since a large number of triterpenoid compound has marked anticancer effects toward various types of cancer cell lines in vitro, this study was carried out to investigate the anticancer effect of CRA in human gastric cancer cell line BGC823 cells and the underlying apoptotic mechanism of CRA was examined in BGC823 cell lines. 28506699 2017
CUI: C0007971
Disease: Cheilitis
Cheilitis
0.010 Biomarker disease BEFREE The main 13-CRA related toxicities were dry skin and cheilitis. 28786105 2017
CUI: C0008626
Disease: Congenital chromosomal disease
Congenital chromosomal disease
0.010 Biomarker group BEFREE Thirteen patients had morphologic and cytogenetic evaluation of marrow cells before 13-CRA treatment, and with one exception, marrow morphologic and cytogenetic abnormalities persisted following 13-CRA administration. 3514807 1986
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.010 Biomarker disease BEFREE ATP-CRA tailored-chemotherapy has the potential to provide a survival benefit in resectable advanced CRC. 31384612 2019
CUI: C0018790
Disease: Cardiac Arrest
Cardiac Arrest
0.010 Biomarker disease BEFREE The cardiac rhythm as primary origin of the CRA was ventricular fibrillation (VF) in 16 patients (61.5%), asystole in 8 patients (34.6%) and ventricular tachycardia (VT) in one patient (3.8%). 29275174 2018
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.010 Biomarker disease BEFREE In conclusion, we demonstrated that NCRAE, a natural extract of chicory (Cichorium intybus) rich in CRA and CQAs improves glucose tolerance and reduces the basal hyperglycemia in STZ diabetic rats. 29325917 2018
CUI: C0024440
Disease: Macular Edema, Cystoid
Macular Edema, Cystoid
0.010 Biomarker disease BEFREE To determine the 2-year efficacy of intravitreal ranibizumab with an L-CRA vs ranibizumab alone for patients with macular edema caused by CRVO. 30347030 2018
CUI: C0029104
Disease: Opioid withdrawal
Opioid withdrawal
0.010 Biomarker disease BEFREE Despite significantly greater improvement by the OPU group, they did not improve to the level of the MAPU group over 12 months, suggesting that they may benefit from A-CRA continuing care up to 12 months, medication to address opioid withdrawal and craving, and the inclusion of opioid-focused A-CRA procedures. 28282523 2017
CUI: C0035412
Disease: Rhabdomyosarcoma
Rhabdomyosarcoma
0.010 Biomarker disease BEFREE Although Surv.m-CRA efficiently replicated and potently induced cell death in all populations of rhabdomyosarcoma cells, the cytotoxic effects were more pronounced in RSC-enriched or RSC-purified cells than in RSC-exiguous or progeny-purified cells. 24467821 2014
CUI: C0042510
Disease: Ventricular Fibrillation
Ventricular Fibrillation
0.010 Biomarker disease BEFREE The cardiac rhythm as primary origin of the CRA was ventricular fibrillation (VF) in 16 patients (61.5%), asystole in 8 patients (34.6%) and ventricular tachycardia (VT) in one patient (3.8%). 29275174 2018
CUI: C0154841
Disease: Central retinal vein occlusion
Central retinal vein occlusion
0.010 Biomarker disease BEFREE To determine the 2-year efficacy of intravitreal ranibizumab with an L-CRA vs ranibizumab alone for patients with macular edema caused by CRVO. 30347030 2018
CUI: C0220611
Disease: Childhood Rhabdomyosarcoma
Childhood Rhabdomyosarcoma
0.010 Biomarker disease BEFREE Although Surv.m-CRA efficiently replicated and potently induced cell death in all populations of rhabdomyosarcoma cells, the cytotoxic effects were more pronounced in RSC-enriched or RSC-purified cells than in RSC-exiguous or progeny-purified cells. 24467821 2014